Skip to Main Content

Paper Details

Clinical and molecular features of pediatric cancer patients with Lynch syndrome.
Pediatr Blood Cancer
6
2022
CMMRD, Lynch syndrome, MLH1, MMR, MMR genes, MSH2, MSH6, cancer, cancer predisposition syndrome, childhood cancer, children, germline heterozygous pathogenic variant, mismatch repair, mismatch repair (MMR) genes, patient, patients, pediatric, pediatric cancer, solid tumors, tumor
Author NameAffiliation
Sarah ScollonBaylor College of Medicine
Jianhong HuBaylor College of Medicine
Viktoriya KorchinaBaylor College of Medicine
Richard A GibbsBaylor College of Medicine
Richard A GibbsBaylor College of Medicine
Richard A GibbsBaylor College of Medicine
Richard A GibbsBaylor College of Medicine
Donna M MuznyBaylor College of Medicine
Donna M MuznyBaylor College of Medicine
Donna M MuznyBaylor College of Medicine
Donna M MuznyBaylor College of Medicine
Angshumoy RoyBaylor College of Medicine
Angshumoy RoyTexas Children's Hospital
Angshumoy RoyBaylor College of Medicine
Donald W ParsonsBaylor College of Medicine
Donald W ParsonsBaylor College of Medicine
Donald W ParsonsBaylor College of Medicine
Donald W ParsonsTexas Children's Hospital
Donald W ParsonsBaylor College of Medicine
Donald W ParsonsTexas Children's Hospital
Donald W ParsonsBaylor College of Medicine
Donald W ParsonsBaylor College of Medicine
Sharon E PlonBaylor College of Medicine
Sharon E PlonBaylor College of Medicine
Sharon E PlonBaylor College of Medicine
  • 1 - 25

Datasets